Relapse of Tobacco Consumption in Patients Treated for Head and Neck Cancer: a Cross Sectional Study
- PDF / 245,528 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 8 Downloads / 212 Views
ORIGINAL ARTICLE
Relapse of Tobacco Consumption in Patients Treated for Head and Neck Cancer: a Cross Sectional Study Jangir Naresh 1 & Khemka Shruti 2 & Bhondve Amit 3 & Singh Akash 1 & Venkatramanu Vinay 2 & Vidyarthi Ajay 2 & Dandekar Mitali 4,1 Received: 2 March 2020 / Accepted: 17 June 2020 # Indian Association of Surgical Oncology 2020
Abstract Head and neck cancers are a major healthcare burden in the Indian Subcontinent mainly due to tobacco consumption. While advances in treatment have resulted in better control rates and survival, relapse of tobacco consumption contributes to recurrences. The authors embarked upon a cross-sectional questionnaire-based study to assess the burden of tobacco relapse along with factors resulting into relapse. Patients on follow-up after treatment of tobacco-related head and neck cancers in a dedicated cancer institute were included in the study. Demographic data was noted, and responses were obtained on a five-point Likert’s scale for reasons of relapse which were analyzed with a median and interquartile range. Predictors of relapse were assessed using multivariate logistic regression analysis. In our sample size of 500, relapse rate was 15%, majority of which occurred in the first year of follow-up when disease was loco-regionally controlled. Most common causative factor for relapse was lower motivation to quit. Care givers must incorporate tobacco cessation counseling as an integral part of head and neck cancer treatment.
Keywords Head and neck cancer . Tobacco relapse . Tobacco cessation
Introduction Indian subcontinent has a large burden of head and neck cancer due to rampant tobacco consumption. Since tobacco consumption incidence and pattern have been established, measures to curb it have borne fruit.[1] Continuation of tobacco habits after diagnosis of cancer is associated with treatment-related side effect, disease recurrence, second primary cancers, and mortality.[2–4] Therefore,
tertiary prevention of tobacco is vital and information about patient’s tobacco habit and factors associated with continued consumption would be important considerations. Literature review suggests prevalence of continued tobacco use among patients with head and neck cancer to range from 20 to 50%.[5, 6] However, there is a paucity of such data from India, which is the hotbed for tobacco-related head and neck cancers particularly on factors that compel patients to continue consuming tobacco after diagnosis despite treatment-related
* Dandekar Mitali [email protected]
Venkatramanu Vinay [email protected]
Jangir Naresh [email protected]
Vidyarthi Ajay [email protected]
Khemka Shruti [email protected]
1
Department of Surgical Oncology, Mahavir Cancer Sansthan, Patna, India
Bhondve Amit [email protected]
2
Mahavir Cancer Sansthan, Patna, India
3
Seth GSMC and KEM Hospital, Mumbai, India
4
Paras Hospital, Patna, India
Singh Akash [email protected]
Indian J Surg Oncol
morbidity.[7] This information is critical because it would enab
Data Loading...
